AT323727B - Verfahren zur herstellung von neuen pyrrolylessigsaurederivaten sowie deren salzen - Google Patents

Verfahren zur herstellung von neuen pyrrolylessigsaurederivaten sowie deren salzen

Info

Publication number
AT323727B
AT323727B AT1093772A AT1093772A AT323727B AT 323727 B AT323727 B AT 323727B AT 1093772 A AT1093772 A AT 1093772A AT 1093772 A AT1093772 A AT 1093772A AT 323727 B AT323727 B AT 323727B
Authority
AT
Austria
Prior art keywords
salts
production
acid derivatives
acidic acid
pyrrolyl
Prior art date
Application number
AT1093772A
Other languages
German (de)
English (en)
Original Assignee
Continental Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BE777207A external-priority patent/BE777207A/xx
Priority claimed from BE785274A external-priority patent/BE785274R/xx
Application filed by Continental Pharma filed Critical Continental Pharma
Application granted granted Critical
Publication of AT323727B publication Critical patent/AT323727B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333—Radicals substituted by oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
AT1093772A 1971-12-23 1972-12-21 Verfahren zur herstellung von neuen pyrrolylessigsaurederivaten sowie deren salzen AT323727B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE777207A BE777207A (en) 1971-12-23 1971-12-23 3-pyrroleacetic acids - analgesics, antipyretics antiinflammatories prepd by hydrolysis of the corresp acid deriv
BE785274A BE785274R (en) 1972-06-22 1972-06-22 Pyrrole-3-acetic acids - useful as antiinflammatory analgesic and anti pyretic agents

Publications (1)

Publication Number Publication Date
AT323727B true AT323727B (de) 1975-07-25

Family

ID=25656964

Family Applications (1)

Application Number Title Priority Date Filing Date
AT1093772A AT323727B (de) 1971-12-23 1972-12-21 Verfahren zur herstellung von neuen pyrrolylessigsaurederivaten sowie deren salzen

Country Status (19)

Country Link
JP (1) JPS5318507B2 (hu)
AR (1) AR208494A1 (hu)
AT (1) AT323727B (hu)
AU (1) AU467602B2 (hu)
CA (1) CA991193A (hu)
CH (1) CH563364A5 (hu)
DD (1) DD104976A5 (hu)
DE (1) DE2261965A1 (hu)
DK (1) DK134599B (hu)
ES (1) ES409944A1 (hu)
FR (1) FR2164857B1 (hu)
GB (1) GB1406330A (hu)
HU (1) HU165900B (hu)
IE (1) IE37237B1 (hu)
IL (1) IL41146A (hu)
NL (1) NL7217521A (hu)
OA (1) OA04523A (hu)
PL (1) PL89071B1 (hu)
SE (1) SE388853B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2645234A1 (de) * 1976-10-07 1978-04-20 Basf Ag 2,5-dialkoxy-3-amino-methyltetrahydrofurane und verfahren zu ihrer herstellung
US4248784A (en) * 1977-02-25 1981-02-03 Sterling Drug Inc. Pyrrole-3-acetamides
DE3026402A1 (de) * 1980-07-11 1982-02-04 Syntex Corp., Palo Alto, Calif. Die verwendung analgetischer und nicht-hormonaler, entzuendungshemmender mittel bei der behandlung von mikrovaskulaeren erkrankungen
US4851427A (en) * 1985-10-25 1989-07-25 Sandoz Pharm. Corp. Pyrrole analogs of mevalonolactone, derivatives thereof and pharmaceutical use
US4973704A (en) * 1985-10-25 1990-11-27 Sandoz Pharm. Corp. Pyrrolyl intermediates in the synthesis of pyrrole analogs of mevalonolactone and derivatives thereof
WO1987002662A2 (en) * 1985-10-25 1987-05-07 Sandoz Ag Heterocyclic analogs of mevalonolactone and derivatives thereof, processes for their production and their use as pharmaceuticals
DE3915450A1 (de) * 1989-05-11 1990-11-15 Gerd Prof Dr Dannhardt Substituierte pyrrolverbindungen und deren anwendung in der pharmazie
US5260451A (en) * 1989-05-11 1993-11-09 Merckle Gmbh Substituted pyrrole compounds and use thereof in pharmaceutical compositions
ES2208964T3 (es) * 1996-12-10 2004-06-16 G.D. SEARLE & CO. Compuestos de pirrolilo substituidos para el tratamiento de la inflamacion.
EP2059504B1 (en) * 2006-08-03 2015-09-09 Rottapharm Biotech S.r.l. 3-substituted-1,5-diarly-2-alkyl-pyrroles highly selective and orally effective cox-2 inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1228301A (hu) * 1968-04-16 1971-04-15

Also Published As

Publication number Publication date
JPS5318507B2 (hu) 1978-06-15
IL41146A (en) 1977-03-31
IE37237B1 (en) 1977-06-08
SE388853B (sv) 1976-10-18
FR2164857B1 (hu) 1976-03-05
DD104976A5 (hu) 1974-04-05
DK134599B (da) 1976-12-06
AU5033872A (en) 1974-06-20
DE2261965A1 (de) 1973-06-28
AU467602B2 (en) 1974-06-20
CA991193A (en) 1976-06-15
JPS4868562A (hu) 1973-09-18
FR2164857A1 (hu) 1973-08-03
AR208494A1 (es) 1977-02-15
NL7217521A (hu) 1973-06-26
IE37237L (en) 1973-06-23
GB1406330A (en) 1975-09-17
OA04523A (fr) 1980-03-30
ES409944A1 (es) 1976-03-16
HU165900B (hu) 1974-12-28
PL89071B1 (en) 1976-10-30
CH563364A5 (hu) 1975-06-30
DK134599C (hu) 1977-05-09

Similar Documents

Publication Publication Date Title
AT324341B (de) Verfahren zur herstellung von neuen pyridinderivaten sowie deren saureadditionssalzen
AT344144B (de) Verfahren zur herstellung von neuen substituierten 3-aminoalkylamino-2-hydroxy-1-phenoxypropanen und von deren saeureadditionssalzen
AT323727B (de) Verfahren zur herstellung von neuen pyrrolylessigsaurederivaten sowie deren salzen
AT332375B (de) Verfahren zur herstellung von neuen aminobenzylaminen sowie deren saureadditionssalzen
AT327163B (de) Verfahren zur herstellung von neuen alkenylbernsteinsauren sowie deren salzen
AT325597B (de) Verfahren zur herstellung von neuen benzobicycloalkanaminen und deren säureadditionssalzen
AT316561B (de) Verfahren zur Herstellung von neuen Pyridylpiperazinen sowie deren Säureadditionssalzen
AT322568B (de) Verfahren zur herstellung von neuen guanidinophenylharnstoffderivaten sowie von deren saeureadditionssalzen
AT310762B (de) Verfahren zur Herstellung von neuen Triazolbenzodiazepin-Derivaten sowie von deren Salzen
AT326128B (de) Verfahren zur herstellung von neuen sulfonamidopyrimidinen sowie deren salzen
AT303734B (de) Verfahren zur Herstellung von neuen N-Vinylchinolonen sowie deren Salzen
AT319954B (de) Verfahren zur Herstellung von neuen Sulfonylaminopyrimidinen sowie deren Salzen
AT321306B (de) Verfahren zur Herstellung von neuen 1-Vinylcarbonyl-piperazin-Derivaten sowie von deren Säureadditionssalzen
AT322571B (de) Verfahren zur herstellung von neuen basisch substituierten thiolcarbamidsaeure-alkylestern sowie von deren saeureadditionssalzen und quartaeren ammoniumsalzen
AT308759B (de) Verfahren zur Herstellung von neuen Benzodiazepinderivaten sowie von deren Salzen
AT323174B (de) Verfahren zur herstellung von neuen derivaten des 1-phenoxy-3-amino-propan-2-ols und deren saureadditionssalzen
AT332379B (de) Verfahren zur herstellung von neuen aminobenzylaminen sowie deren saureadditionssalzen
ATA642975A (de) Verfahren zur herstellung von neuen aminobenzylaminen sowie deren saureadditionssalzen
ATA502075A (de) Verfahren zur herstellung von neuen aminobenzylaminen sowie deren saureadditionssalzen
AT332860B (de) Verfahren zur herstellung von neuen spiro-cycloaliphatischen aminen sowie deren saureadditionssalzen
AT286267B (de) Verfahren zur Herstellung von neuen Amino-dihalogenphenyläthanolaminen sowie von deren Säureadditionssalzen
AT311361B (de) Verfahren zur Herstellung von neuen Sulfonylaminopyrimidinen sowie deren Salzen
ATA237274A (de) Verfahren zur herstellung neuer indenopyridinderivate sowie von deren saureadditionssalzen
AT342027B (de) Verfahren zur herstellung von neuen aminobenzoesauren sowie deren saureadditionssalzen
ATA915475A (de) Verfahren zur herstellung von neuen adeninderivaten sowie deren saureadditionssalzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee